TaizinaiGroup, a China-basedlactobacillus drink manufacturer, has raised $40 million in private equity funding from Actis. The infusion is part of a larger $73 million financing, which also includes Goldman Sachs and Morgan Stanley. www.act.is
TaizinaiGroup, a China-basedlactobacillus drink manufacturer, has raised $40 million in private equity funding from Actis. The infusion is part of a larger $73 million financing, which also includes Goldman Sachs and Morgan Stanley. www.act.is
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: